A股異動 | 南京證券(601990.SH)逆勢漲逾4% 控股股東此前承諾三年內不減持
格隆匯6月15日丨2018年6月,南京證券成功在上交所上市交易,同時也產生了合計12.38億股的首次公開發行限售股。上市滿三年的南京證券(601990.SH)今日迎來限售股解禁,解禁金額將超100億元。南京證券(601990.SH)今天卻逆勢漲逾4%,報9.73元,總市值359億元。6月4日晚間,南京證券公吿稱,近日收到控股股東紫金集團及其子公司紫金資管、紫金信託出具承諾,基於對南京證券未來發展前景的信心及長期投資價值的認可,三名股東承諾36個月內不減持合計持有的10.23億股南京證券限售股,約佔本次解禁股份的82.67%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.